3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide

C33H35N5O4 — CID 98442519

IUPAC3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide
SMILESCOc1ccc(-c2ccc(N3CCN(C(=O)CN(C(=O)c4cccc(OC)c4)[C@H](C)c4ccccc4)CC3)nn2)cc1
InChIInChI=1S/C33H35N5O4/c1-24(25-8-5-4-6-9-25)38(33(40)27-10-7-11-29(22-27)42-3)23-32(39)37-20-18-36(19-21-37)31-17-16-30(34-35-31)26-12-14-28(41-2)15-13-26/h4-17,22,24H,18-21,23H2,1-3H3/t24-/m1/s1
InChIKeyWJIJCECEGKXNDZ-XMMPIXPASA-N
MW565.67 g/mol
LogP4.71
Rot. Bonds9

About 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide

3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide (PubChem CID 98442519) has the molecular formula C33H35N5O4 and a molecular weight of 565.67 g/mol. Its IUPAC name is 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide.

Molecular Properties

Compound Name3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide
PubChem CID98442519
Molecular FormulaC33H35N5O4
Molecular Weight565.67 g/mol
Exact Mass565.27
IUPAC Name3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide
SMILESCOc1ccc(-c2ccc(N3CCN(C(=O)CN(C(=O)c4cccc(OC)c4)[C@H](C)c4ccccc4)CC3)nn2)cc1
InChIInChI=1S/C33H35N5O4/c1-24(25-8-5-4-6-9-25)38(33(40)27-10-7-11-29(22-27)42-3)23-32(39)37-20-18-36(19-21-37)31-17-16-30(34-35-31)26-12-14-28(41-2)15-13-26/h4-17,22,24H,18-21,23H2,1-3H3/t24-/m1/s1
InChIKeyWJIJCECEGKXNDZ-XMMPIXPASA-N
XLogP4.71
TPSA88.10 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500565.67
LogP ≤ 54.71
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide?
The IUPAC name of 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide (CID 98442519) is 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide.
What is the SMILES notation for 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide?
The canonical SMILES for 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide is COc1ccc(-c2ccc(N3CCN(C(=O)CN(C(=O)c4cccc(OC)c4)[C@H](C)c4ccccc4)CC3)nn2)cc1.
What is the InChIKey of 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide?
The InChIKey is WJIJCECEGKXNDZ-XMMPIXPASA-N. The full InChI is InChI=1S/C33H35N5O4/c1-24(25-8-5-4-6-9-25)38(33(40)27-10-7-11-29(22-27)42-3)23-32(39)37-20-18-36(19-21-37)31-17-16-30(34-35-31)26-12-14-28(41-2)15-13-26/h4-17,22,24H,18-21,23H2,1-3H3/t24-/m1/s1.
What are the key properties of 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide?
3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide has a molecular weight of 565.67 g/mol, XLogP of 4.71, 9 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methoxy-N-[2-[4-[6-(4-methoxyphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1R)-1-phenylethyl]benzamide is sourced from PubChem (CID 98442519), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).